期刊文献+

曲美他嗪联合稳心颗粒治疗不稳定性心绞痛的价值 被引量:12

Value of Trimetazidine combined with Wenxin Granule in treatment of unstable angina pectoris
下载PDF
导出
摘要 目的探讨曲美他嗪与稳心颗粒联合治疗不稳定性心绞痛的临床疗效。方法选取76例不稳定性心绞痛患者,按数字表法分为观察组和对照组各38例,所有患者均给予常规治疗,对照组在常规治疗的基础上加用曲美他嗪,观察组在常规治疗的基础上给予曲美他嗪联合稳心颗粒治疗。结果观察组有效率明显高于对照组;治疗14 d后心绞痛发作次数、持续时间均明显低于对照组(P<0.01)。结论曲美他嗪联合稳心颗粒有利于改善患者心绞痛症状,提高治疗效果。 Objective To investigate the clinical efficacy of trimetazidine combined with Wenxin Granule in the treatment of unstable angina. Methods 76 patients with unstable angina were divided into observation group and control group according to the number table method,38 cases in each group,all patients were given conventional treatment,patients in the control group were given trimetazidine on the basis of conventional therapy,patients in the observation group were given Wenxin Granule on the basis of treatment as control group.Results The effective rate in the observation group was better than that in the control group,after treatment about 14 d,the frequency and duration about angina pectoris were significantly lower than that in the control group( P〈0. 01). Conclusions Trimetazidine combined with Wenxin Granule is conducive to improve the symptoms of angina pectoris,and improve the treatment effect.
作者 黄振华
出处 《齐齐哈尔医学院学报》 2015年第15期2212-2213,共2页 Journal of Qiqihar Medical University
关键词 曲美他嗪 稳心颗粒 不稳定性心绞痛 Trimetazidine Wenxin Granule Unstable angina pectoris
  • 相关文献

参考文献4

二级参考文献51

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
  • 2徐险峰.通心络胶囊联合曲美他嗪治疗不稳定型心绞痛疗效观察[J].临床和实验医学杂志,2007,6(4):66-67. 被引量:15
  • 3Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 4Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
  • 5Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
  • 6CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
  • 7Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
  • 8Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
  • 9Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.
  • 10Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505.

共引文献2164

同被引文献142

引证文献12

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部